Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds

March 30, 2017 updated by: Dr. Jozsef Constantin Széles, Medical University of Vienna

Evaluation of Electrical Auricular Vagal Nerve Stimulation Effects on Parameters of Wound Healing in Chronic Diabetic Wounds - Pilot Study

The purpose of this pilot study is to evaluate the effect of auricular autonomous nervous system stimulation on vital parameters of wound healing in diabetics. It is investigated if auricular vagal nerve stimulation has an effect on heart rate variability as well as peripheral local blood perfusion, and if this effect depends on the health status of the study participants (diseased/healthy).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1090
        • University Clinic for Surgery, Department of Transplantation, Medical University Vienna

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diabetes mellitus type 2
  • ulcus cruris (plantar)
  • min. 6 weeks of standard wound therapy without success
  • intact big toe on wound side

Exclusion Criteria:

  • participation in a clinical trial in the last 5 weeks
  • confounding medical treatment, e.g. prostaglandin
  • vascular diseases other than peripheral arterial occlusive disease
  • diseases which may affect the autonomous nervous system or wound healing, except diabetic concomitant diseases (e.g., polyneuropathy, angiopathy)
  • drug abuse
  • active implanted devices
  • pregnancy or nursing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: auricular vagal nerve stimulation

Study participants (healthy and diabetics) are treated with auricular vagal nerve stimulation using four needle electrodes connected to an electrical stimulation device (PrimeStim). After an acclimatization phase the stimulation is turned on for 20 minutes followed by 20 minutes of paused stimulation, 20 minutes of stimulation, and another 10 minutes paused stimulation. This intervention is repeated on four consecutive days. Needle electrodes stay fixed over the whole study period.

Two different stimulation schemes are tested, each being assessed twice in random order. Stimulation amplitudes are adjusted with respect to a distinct but comfortable sensation at the auricle.

During the described protocol various biosignals are continuously recorded, including ECG, respiration, blood perfusion, oxygen saturation, transcutaneous oxygen tension, blood pressure and skin temperature.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in heart rate variability (HRV) related to physiological state (diabetics/healthy)
Time Frame: within 4 days of intervention

Heart rate variability will be assessed as, e.g., standard deviation in heart rate over a time window of 5 minutes (30 seconds overlap).

Changes in mean value and standard deviation of heart rate variability between healthy and diabetic patients will be assessed using statistical tests.

within 4 days of intervention
change in local blood perfusion index (BPI) related to physiological state (diabetics/healthy)
Time Frame: within 4 days of intervention

Blood perfusion index at the foot will be assessed as peak-peak amplitude (systolic to diastolic) divided by the mean signal value of optically measured blood perfusion.

Changes in mean value and standard deviation of local blood perfusion index between healthy and diabetic patients will be assessed using statistical tests.

within 4 days of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse effects of stimulation
Time Frame: within 4 days of intervention
within 4 days of intervention
Change in HRV and local BPI due to distinct stimulation patterns
Time Frame: within 4 days of intervention

Two distinct stimulation patterns are tested during intervention.

Changes in mean value and standard deviation of HRV/BPI due to these stimulation patterns will be assessed using statistical tests.

within 4 days of intervention
Change of local BPI in upper and lower extremities
Time Frame: within 4 days of intervention

Local BPI is assessed using optical sensors on the foot and the finger of participants.

Changes in mean value of BPI are analyzed using statistical tests.

within 4 days of intervention
Changes in blood pressure
Time Frame: within 4 days of intervention
Blood pressure is continuously measured using inflatable finger cuffs.
within 4 days of intervention
Changes in respiratory activity
Time Frame: within 4 days of intervention
Respiratory activity is monitored using a respiratory belt.
within 4 days of intervention
Changes in oxygen saturation of the toe and wound
Time Frame: within 4 days of intervention
within 4 days of intervention
Changes in partial transcutaneous oxygen pressure of the wound region
Time Frame: within 4 days of intervention
within 4 days of intervention
Changes in foot skin temperature
Time Frame: within 4 days of intervention
within 4 days of intervention
Changes of C reactive protein- and leukocyte-concentration in serum
Time Frame: within 4 days of intervention
within 4 days of intervention
Tolerance of stimulation
Time Frame: within 4 days of intervention
Tolerance of stimulation is assessed by survey.
within 4 days of intervention
Perception of Stimulation
Time Frame: within 4 days of intervention
Perception of stimulation is assessed by survey.
within 4 days of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jozsef C Széles, Dr.med., University Clinic for Surgery, Department of Transplantation, Medical University Vienna

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Actual)

April 13, 2015

Study Completion (Actual)

April 13, 2015

Study Registration Dates

First Submitted

March 20, 2014

First Submitted That Met QC Criteria

March 27, 2014

First Posted (Estimate)

March 28, 2014

Study Record Updates

Last Update Posted (Actual)

March 31, 2017

Last Update Submitted That Met QC Criteria

March 30, 2017

Last Verified

March 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Diabetic Foot Ulcers

Clinical Trials on PrimeStim

Subscribe